Cargando…
P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428339/ http://dx.doi.org/10.1097/01.HS9.0000968336.17893.02 |
| _version_ | 1785090444961513472 |
|---|---|
| author | Ghobadi, Armin Aldoss, Ibrahim Maude, Shannon S Wayne, Alan Bhojwani, Deepa Bajel, Ashish Dholaria, Bhagirathbhai Faramand, Rawan Mattison, Ryan Rettig, Michael Bakkacha, Ouiam Muth, John Pannunzio, Angela Ramsey, Brett Mcnulty, Eileen Cooper, Matthew Davidson-Moncada, Jan Jacobs, Kenneth Dipersio, John |
| author_facet | Ghobadi, Armin Aldoss, Ibrahim Maude, Shannon S Wayne, Alan Bhojwani, Deepa Bajel, Ashish Dholaria, Bhagirathbhai Faramand, Rawan Mattison, Ryan Rettig, Michael Bakkacha, Ouiam Muth, John Pannunzio, Angela Ramsey, Brett Mcnulty, Eileen Cooper, Matthew Davidson-Moncada, Jan Jacobs, Kenneth Dipersio, John |
| author_sort | Ghobadi, Armin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428339 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283392023-08-17 P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) Ghobadi, Armin Aldoss, Ibrahim Maude, Shannon S Wayne, Alan Bhojwani, Deepa Bajel, Ashish Dholaria, Bhagirathbhai Faramand, Rawan Mattison, Ryan Rettig, Michael Bakkacha, Ouiam Muth, John Pannunzio, Angela Ramsey, Brett Mcnulty, Eileen Cooper, Matthew Davidson-Moncada, Jan Jacobs, Kenneth Dipersio, John Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428339/ http://dx.doi.org/10.1097/01.HS9.0000968336.17893.02 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ghobadi, Armin Aldoss, Ibrahim Maude, Shannon S Wayne, Alan Bhojwani, Deepa Bajel, Ashish Dholaria, Bhagirathbhai Faramand, Rawan Mattison, Ryan Rettig, Michael Bakkacha, Ouiam Muth, John Pannunzio, Angela Ramsey, Brett Mcnulty, Eileen Cooper, Matthew Davidson-Moncada, Jan Jacobs, Kenneth Dipersio, John P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_full | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_fullStr | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_full_unstemmed | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_short | P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL) |
| title_sort | p356: phase 1/2 dose-escalation study of anti-cd7 allogenic car-t cell in relapsed or refractory(r/r) t-cell acute lymphoblastic leukemia/lymphoblastic lymphoma(t-all/lbl) |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428339/ http://dx.doi.org/10.1097/01.HS9.0000968336.17893.02 |
| work_keys_str_mv | AT ghobadiarmin p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT aldossibrahim p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT maudeshannon p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT swaynealan p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT bhojwanideepa p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT bajelashish p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT dholariabhagirathbhai p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT faramandrawan p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT mattisonryan p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT rettigmichael p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT bakkachaouiam p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT muthjohn p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT pannunzioangela p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT ramseybrett p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT mcnultyeileen p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT coopermatthew p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT davidsonmoncadajan p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT jacobskenneth p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl AT dipersiojohn p356phase12doseescalationstudyofanticd7allogeniccartcellinrelapsedorrefractoryrrtcellacutelymphoblasticleukemialymphoblasticlymphomatalllbl |